DePuy Synthes invests €36M to develop medical 3D printing

Johnson & Johnson-owned franchise, DePuy Synthes Ireland is investing €36 million to establish a 3D Printing Development and Launch Center in order to accelerate its additive manufacturing projects. The company is a global leader in orthopaedic and neurological solutions including hip and knee replacement joints. This new investment focusing strictly on 3D technologies should assert their key role in offering solutions for the medical field, particularly for the orthopaedic field.

DePuy Synthes was acquired in 1998 by Johnson & Johnson and already employs 1,000 people at its Cork facility in Ireland. They are in the process of hiring 30 more people. Indeed, the company in the past had partnered with Aspect Biosystems in order to bioprint human tissues and transform health care thanks to 3D technologies. Therefore, it is a real success for them to have received €36 million from the government in order to make new investments.

A centre dedicated to 3D printing in the medical field

Welcoming the announcement on behalf of DePuy Synthes, Shannon Crespin, VP Global Supply Chain at DePuy Synthes said, “I’m delighted to be here for today’s announcement, which marks the next phase in the exciting R&D activity being undertaken at this Innovation Centre. As the world’s most comprehensive medical devices business, our expert team continues to develop ground-breaking healthcare solutions, underlining our ongoing commitment to improving patient outcomes and shaping the future of healthcare delivery”.